| Financial Year |
March 31 2023 |
| Monetary Funds |
431,811,599.95 |
| Held-for-trading Financial Assets |
12,500,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
222,539,225.27 |
| Advances to Suppliers |
5,990,862.86 |
| Other Receivables |
5,012,907.97 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
31,525,182.22 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
14,051,156.92 |
| Total Current Assets |
769,265,651.32 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
8,333,337.49 |
| Long-term Equity Investment |
16,144,580.83 |
| Investment Properties |
-- |
| Fixed Assetes |
245,627,703.41 |
| Under-construction Projects |
11,292,858.11 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
61,686,248.63 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
299,090.65 |
| Deferred Income Tax Assets |
9,804,120.99 |
| Other Non-Current Assets |
5,170,078.17 |
| Sub-Total of Non-Current Assets |
358,805,252.18 |
| Total Assets |
1,128,070,903.50 |
| Short-Term Loans |
29,922,666.70 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,967,080.00 |
| Accounts Payable |
67,774,731.57 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
5,749,900.20 |
| Taxes Payable |
822,237.18 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,916,532.71 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
124,369,429.30 |
| Long-term Loans |
-- |
| Bonds Payable |
203,629,364.60 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
206,487,230.42 |
| Total Liabilities |
330,856,659.72 |
| Paid-In Capital(Or Share Stock) |
81,840,000.00 |
| Capital Surplus |
360,888,906.49 |
| Surplus Reserve |
40,920,000.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
239,333,138.42 |
| Minority Stockholder's Interest |
-111,388.70 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
797,325,632.48 |
| Owner's Equity（Stockholder's Equity） |
797,214,243.78 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,128,070,903.50 |
